349 related articles for article (PubMed ID: 35512806)
21. Inhibition of UDP-Glucuronosyltransferase Enzymes by Major Cannabinoids and Their Metabolites.
Nasrin S; Watson CJW; Bardhi K; Fort G; Chen G; Lazarus P
Drug Metab Dispos; 2021 Dec; 49(12):1081-1089. PubMed ID: 34493601
[TBL] [Abstract][Full Text] [Related]
22. Knowledge of Tetrahydrocannabinol and Cannabidiol Levels Among Cannabis Consumers in the United States and Canada.
Hammond D; Goodman S
Cannabis Cannabinoid Res; 2022 Jun; 7(3):345-354. PubMed ID: 33998866
[No Abstract] [Full Text] [Related]
23. Mechanisms of Action and Pharmacokinetics of Cannabis.
Chayasirisobhon S
Perm J; 2020 Dec; 25():1-3. PubMed ID: 33635755
[TBL] [Abstract][Full Text] [Related]
24. Cannabinoid tetrad effects of oral Δ9-tetrahydrocannabinol (THC) and cannabidiol (CBD) in male and female rats: sex, dose-effects and time course evaluations.
Moore CF; Weerts EM
Psychopharmacology (Berl); 2022 May; 239(5):1397-1408. PubMed ID: 34652500
[TBL] [Abstract][Full Text] [Related]
25. Cannabinoid-Induced Stereoselective Inhibition of R-S-Oxazepam Glucuronidation: Cannabinoid-Oxazepam Drug Interactions.
Bardhi K; Coates S; Chen G; Lazarus P
Pharmaceutics; 2024 Feb; 16(2):. PubMed ID: 38399297
[TBL] [Abstract][Full Text] [Related]
26. Effects of a combination of cannabidiol and delta-9-tetrahydrocannabinol on key biological functions of HTR-8/SVneo extravillous trophoblast cells.
Alves P; Amaral C; Teixeira N; Correia-da-Silva G
Toxicology; 2023 Aug; 495():153614. PubMed ID: 37567336
[TBL] [Abstract][Full Text] [Related]
27. Randomized, double-blind, placebo-controlled study about the effects of cannabidiol (CBD) on the pharmacokinetics of Delta9-tetrahydrocannabinol (THC) after oral application of THC verses standardized cannabis extract.
Nadulski T; Pragst F; Weinberg G; Roser P; Schnelle M; Fronk EM; Stadelmann AM
Ther Drug Monit; 2005 Dec; 27(6):799-810. PubMed ID: 16306858
[TBL] [Abstract][Full Text] [Related]
28. Homegrown perceptions about the medical use and potential abuse of CBD and THC.
McFadden BR; Malone T
Addict Behav; 2021 Apr; 115():106799. PubMed ID: 33387977
[TBL] [Abstract][Full Text] [Related]
29. Involvement of esterases in the pulmonary metabolism of beclomethasone dipropionate and the potential influence of cannabis use.
Qian Y; Melchert PW; Markowitz JS
Chem Biol Interact; 2022 Dec; 368():110228. PubMed ID: 36283465
[TBL] [Abstract][Full Text] [Related]
30. Current Cannabidiol Safety: A Review.
Singh C; Rao K; Yadav N; Vashist Y; Chugh P; Bansal N; Minocha N
Curr Drug Saf; 2023; 18(4):465-473. PubMed ID: 36056846
[TBL] [Abstract][Full Text] [Related]
31. Copper Stimulation of Tetrahydrocannabinol and Cannabidiol Production in Hemp (
Cahill MS; Arsenault T; Bui TH; Zuverza-Mena N; Bharadwaj A; Prapayotin-Riveros K; White JC; Dimkpa CO
J Agric Food Chem; 2024 Apr; 72(13):6921-6930. PubMed ID: 38516700
[TBL] [Abstract][Full Text] [Related]
32. CannaCount: an improved metric for quantifying estimates of maximum possible cannabinoid exposure.
Lambros AM; Sagar KA; Dahlgren MK; Kosereisoglu D; El-Abboud C; Smith RT; Gruber SA
Sci Rep; 2023 Apr; 13(1):5869. PubMed ID: 37041309
[TBL] [Abstract][Full Text] [Related]
33. Chemical transformation of cannabidiol into psychotropic cannabinoids under acidic reaction conditions: Identification of transformed products by GC-MS.
Jeong M; Lee S; Seo C; Kwon E; Rho S; Cho M; Kim MY; Lee W; Lee YS; Hong J
J Food Drug Anal; 2023 Mar; 31(1):165-176. PubMed ID: 37224558
[TBL] [Abstract][Full Text] [Related]
34. Development and Verification of a Linked
Patilea-Vrana GI; Unadkat JD
Drug Metab Dispos; 2021 Jul; 49(7):509-520. PubMed ID: 33952608
[TBL] [Abstract][Full Text] [Related]
35. An exploratory study of the combined effects of orally administered methylphenidate and delta-9-tetrahydrocannabinol (THC) on cardiovascular function, subjective effects, and performance in healthy adults.
Kollins SH; Schoenfelder EN; English JS; Holdaway A; Van Voorhees E; O'Brien BR; Dew R; Chrisman AK
J Subst Abuse Treat; 2015 Jan; 48(1):96-103. PubMed ID: 25175495
[TBL] [Abstract][Full Text] [Related]
36. Comparative Pharmacokinetics of Commercially Available Cannabidiol Isolate, Broad-Spectrum, and Full-Spectrum Products.
Berthold EC; Kamble SH; Kanumuri SRR; Kuntz MA; Senetra AS; Chiang YH; McMahon LR; McCurdy CR; Sharma A
Eur J Drug Metab Pharmacokinet; 2023 Jul; 48(4):427-435. PubMed ID: 37337087
[TBL] [Abstract][Full Text] [Related]
37. Receptor-mediated effects of Δ
Preteroti MW; Traboulsi H; Greiss P; Lapohos O; Fonseca GJ; Eidelman DH; Baglole CJ
Immunol Cell Biol; 2023 Feb; 101(2):156-170. PubMed ID: 36510483
[TBL] [Abstract][Full Text] [Related]
38. Differences in prescribed medicinal cannabis use by cannabinoid product composition: Findings from the cannabis as medicine survey 2020 (CAMS-20) Australia-wide study.
Trevitt BT; Bailey S; Mills L; Arkell TR; Suraev A; McGregor IS; Lintzeris N
PLoS One; 2024; 19(2):e0297092. PubMed ID: 38354169
[TBL] [Abstract][Full Text] [Related]
39. Determination of cannabinoids in urine, oral fluid and hair samples after repeated intake of CBD-rich cannabis by smoking.
Gerace E; Bakanova SP; Di Corcia D; Salomone A; Vincenti M
Forensic Sci Int; 2021 Jan; 318():110561. PubMed ID: 33172758
[TBL] [Abstract][Full Text] [Related]
40. Drug Interactions of Tetrahydrocannabinol and Cannabidiol in Cannabinoid Drugs.
Herdegen T; Cascorbi I
Dtsch Arztebl Int; 2023 Dec; 120(49):833-840. PubMed ID: 37874128
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]